Crossmark

Relapses and outcomes of systemic chemo-free therapies combined with intravitreous methotrexate in isolated primary vitreoretinal lymphoma: an analysis based on two prospective cohort studies

Crossref DOI link: https://doi.org/10.1007/s00277-025-06414-x

Published Online: 2025-05-26

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Hongyun

Zhuang, Zhe

Zhang, Xiao

Zhou, Daobin

Zhang, Meifen

Zhang, Wei
Funding

Funding for this research was provided by:

National High Level Hospital Clinical Research Funding (2022-PUMCH-B-047, 2022-PUMCH-C-038)
License Information

Text and Data Mining valid from 2025-05-26

Version of Record valid from 2025-05-26
More Information

Article History

Received: 31 December 2024

Accepted: 13 May 2025

First Online: 26 May 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking Union Medical College Hospital. Informed consent had been acquired at baseline for all participants.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below